Clinical trial
Addendum to Protocol CS-03: Clinical Evaluation of Safety and Effectiveness of the BackBeat Medical Moderato System in Patients With Hypertension: A Double-Blind Randomized Trial, NCT02837445
NCT05086523 is registered in ClinicalTrials.gov with BackBeat Medical Inc as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Addendum to Protocol CS-03: Clinical Evaluation of Safety and Effectiveness of the BackBeat Medical Moderato System in Patients With Hypertension: A Double-Blind Randomized Trial, NCT02837445
- Lead sponsor
- BackBeat Medical Inc
- Phase
- Phase 1/2
- Overall status
- Completed
- Start date
- October 25, 2021
- Completion date
- August 11, 2023
- Enrollment
- 28 (actual)
- Sites
- 6
Conditions
As the registry lists them; a condition with its own page is linked.
hypertension,essential, systolic hypertension